Published in Am J Pathol on March 01, 2002
Ultrastructural changes in dysferlinopathy support defective membrane repair mechanism. J Clin Pathol (2005) 1.31
Differential immunohistological features of inflammatory myopathies and dysferlinopathy. J Korean Med Sci (2009) 0.93
Dysferlin and animal models for dysferlinopathy. J Toxicol Pathol (2012) 0.86
Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice. J Proteome Res (2007) 0.86
Comparative Gene Expression Analysis in the Skeletal Muscles of Dysferlin-deficient SJL/J and A/J Mice. J Toxicol Pathol (2011) 0.81
Normal development of mice deficient in beta 2M, MHC class I proteins, and CD8+ T cells. Science (1990) 8.17
Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet (1998) 4.38
A gene related to Caenorhabditis elegans spermatogenesis factor fer-1 is mutated in limb-girdle muscular dystrophy type 2B. Nat Genet (1998) 3.76
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
Helper (CD4(+)) and cytotoxic (CD8(+)) T cells promote the pathology of dystrophin-deficient muscle. Clin Immunol (2001) 1.94
Expression of immunoreactive major histocompatibility complex products in human skeletal muscles. Ann Neurol (1988) 1.94
Dysferlin deletion in SJL mice (SJL-Dysf) defines a natural model for limb girdle muscular dystrophy 2B. Nat Genet (1999) 1.93
Major histocompatibility complex class I antigen expression, immunolocalization of interferon subtypes, and T cell-mediated cytotoxicity in myopathies. Hum Pathol (1989) 1.89
The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis. Exp Cell Res (1993) 1.74
Myonuclear apoptosis in dystrophic mdx muscle occurs by perforin-mediated cytotoxicity. J Clin Invest (1997) 1.61
Strain-dependent vascular remodeling phenotypes in inbred mice. Am J Pathol (2000) 1.48
MHC class I-deficient mice. Adv Immunol (1994) 1.46
Blood borne macrophages are essential for the triggering of muscle regeneration following muscle transplant. Neuromuscul Disord (1999) 1.45
RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol (1996) 1.32
Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s). Hum Mol Genet (1999) 1.31
Macrophages enhance muscle satellite cell proliferation and delay their differentiation. Muscle Nerve (1999) 1.25
Identical dysferlin mutation in limb-girdle muscular dystrophy type 2B and distal myopathy. Neurology (2000) 1.25
Expression of class I and class II MHC antigens in neuromuscular diseases. J Neurol Sci (1989) 1.25
Splicing mutation in dysferlin produces limb-girdle muscular dystrophy with inflammation. Am J Med Genet (2000) 1.17
Cloning of the mouse dysferlin gene and genomic characterization of the SJL-Dysf mutation. Neuroreport (2001) 1.13
beta2-microglobulin dependence of the lupus-like autoimmune syndrome of MRL-lpr mice. J Immunol (1996) 1.12
Eosinophilia of dystrophin-deficient muscle is promoted by perforin-mediated cytotoxicity by T cell effectors. Am J Pathol (2000) 1.11
Bcl-2 expression identifies an early stage of myogenesis and promotes clonal expansion of muscle cells. J Cell Biol (1998) 1.09
Muscle injury and repair. Phys Med Rehabil Clin N Am (2000) 1.05
Pro- and anti-apoptotic members of the Bcl-2 family in skeletal muscle: a distinct role for Bcl-2 in later stages of myogenesis. Dev Dyn (2001) 0.99
Spontaneous myopathy in the SJL/J mouse: pathology and strength loss. Muscle Nerve (1997) 0.98
Nitric oxide production in relation to spontaneous B-cell lymphoma and myositis in SJL mice. Cancer Res (1995) 0.95
Effect of MHC class I and CD8 cell deficiency on experimental autoimmune myasthenia gravis pathogenesis. J Immunol (1994) 0.86
Phenotypic variation in a large Japanese family with Miyoshi myopathy with nonsense mutation in exon 19 of dysferlin gene. J Neurol Sci (2001) 0.86
Experimental autoimmune myositis in SJL/J mice produced by immunization with syngeneic myosin B fraction. Transfer by both immunoglobulin G and T cells. J Neurol Sci (1996) 0.85
MRF4 can substitute for myogenin during early stages of myogenesis. Dev Dyn (1997) 0.85
Necrotizing myopathy in SJL mice. Muscle Nerve (1988) 0.84
Experimental autoimmune inflammatory myopathy. J Neuropathol Exp Neurol (1987) 0.83
The host environment determines strain-specific differences in the timing of skeletal muscle regeneration: cross-transplantation studies between SJL/J and BALB/c mice. J Anat (1997) 0.83
Experimental models of inflammatory myopathies. Baillieres Clin Neurol (1993) 0.82
Denervation enhances spontaneous inflammatory myopathy in SJL mice. Muscle Nerve (1999) 0.78
Inhibition of fasL sustains phagocytic cells and delays myogenesis in regenerating muscle fibers. J Leukoc Biol (2001) 0.78
TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration. EMBO J (2006) 1.73
Disruption of the COP9 signalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E, and early embryonic death. Mol Cell Biol (2003) 1.46
Inhibition of apoptosis improves outcome in a model of congenital muscular dystrophy. J Clin Invest (2004) 1.41
A unique library of myogenic cells from facioscapulohumeral muscular dystrophy subjects and unaffected relatives: family, disease and cell function. Eur J Hum Genet (2011) 1.14
Pathology is alleviated by doxycycline in a laminin-alpha2-null model of congenital muscular dystrophy. Ann Neurol (2009) 1.09
Regeneration of transgenic skeletal muscles with altered timing of expression of the basic helix-loop-helix muscle regulatory factor MRF4. Am J Pathol (2003) 0.93
Immortalization of mouse myogenic cells can occur without loss of p16INK4a, p19ARF, or p53 and is accelerated by inactivation of Bax. BMC Cell Biol (2004) 0.89
Ku70 regulates Bax-mediated pathogenesis in laminin-alpha2-deficient human muscle cells and mouse models of congenital muscular dystrophy. Hum Mol Genet (2009) 0.87
Diseased muscles that lack dystrophin or laminin-alpha2 have altered compositions and proliferation of mononuclear cell populations. BMC Neurol (2005) 0.83
Proinflammatory signals and the loss of lymphatic vessel hyaluronan receptor-1 (LYVE-1) in the early pathogenesis of laminin alpha2-deficient skeletal muscle. J Histochem Cytochem (2011) 0.82
Prdm1 (Blimp-1) and the expression of fast and slow myosin heavy chain isoforms during avian myogenesis in vitro. PLoS One (2010) 0.82
Bcl-2 inhibits the innate immune response during early pathogenesis of murine congenital muscular dystrophy. PLoS One (2011) 0.80
Peripheral nerve pathology, including aberrant Schwann cell differentiation, is ameliorated by doxycycline in a laminin-α2-deficient mouse model of congenital muscular dystrophy. Hum Mol Genet (2011) 0.76